CA3142510C - Preparation d'un lyophilisat d'annamycine preliposomique - Google Patents

Preparation d'un lyophilisat d'annamycine preliposomique

Info

Publication number
CA3142510C
CA3142510C CA3142510A CA3142510A CA3142510C CA 3142510 C CA3142510 C CA 3142510C CA 3142510 A CA3142510 A CA 3142510A CA 3142510 A CA3142510 A CA 3142510A CA 3142510 C CA3142510 C CA 3142510C
Authority
CA
Canada
Prior art keywords
annamycin
solution
composition
adjusted
dmpg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3142510A
Other languages
English (en)
Other versions
CA3142510A1 (fr
Inventor
Donald PICKER
Waldemar Priebe
Original Assignee
University of Texas System
Moleculin Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, Moleculin Biotech Inc filed Critical University of Texas System
Priority claimed from PCT/US2020/039620 external-priority patent/WO2020264160A1/fr
Publication of CA3142510A1 publication Critical patent/CA3142510A1/fr
Application granted granted Critical
Publication of CA3142510C publication Critical patent/CA3142510C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne un procédé de fabrication d'un lyophilisat d'annamycine préliposomique, la composition obtenue par le procédé et l'utilisation de la composition ainsi obtenue dans le traitement du cancer. Plus spécifiquement, l'invention concerne un procédé de fabrication d'annamycine lyophilisée comprenant les étapes consistant à : fabriquer une solution d'annamycine, d'un ou plusieurs lipides, d'un ou plusieurs tensioactifs non ioniques, et d'un ou plusieurs solvants, filtrer de manière stérile la solution contenant des lipides d'annamycine ; et lyophiliser la solution contenant des lipides de l'annamycine pour obtenir un lyophilisat d'annamycine préliposomique.
CA3142510A 2019-06-28 2020-06-25 Preparation d'un lyophilisat d'annamycine preliposomique Active CA3142510C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962868184P 2019-06-28 2019-06-28
US62/868,184 2019-06-28
PCT/US2020/039620 WO2020264160A1 (fr) 2019-06-28 2020-06-25 Préparation d'un lyophilisat d'annamycine préliposomique

Publications (2)

Publication Number Publication Date
CA3142510A1 CA3142510A1 (fr) 2020-12-30
CA3142510C true CA3142510C (fr) 2025-12-09

Family

ID=

Similar Documents

Publication Publication Date Title
AU2024203598B2 (en) Preparation of preliposomal annamycin lyophilizate
US9005655B2 (en) Non-pegylated long-circulating liposomes
EP3603620B1 (fr) Composition de liposome et composition pharmaceutique
AU2024203593A1 (en) Method of reconstituting liposomal annamycin
EP1435231B1 (fr) Liposomes non-pegylés à longue durée de circulation
CA3142510C (fr) Preparation d'un lyophilisat d'annamycine preliposomique
AU2020303572B2 (en) Preparation of preliposomal Annamycin lyophilizate
HK40073244A (en) Method of reconstituting liposomal annamycin
HK40073244B (en) Method of reconstituting liposomal annamycin
PL190077B1 (pl) Liposomowy preparat doksorubicyny, sposób jego wytwarzania oraz przeciwnowotworowa kompozycja farmaceutyczna zawierająca ten preparat